One of the biggest issues that has stood in the way of medical marijuana patients and healthcare professionals has been the challenge of how to determine the precise dosage to be administered in order to attain the required therapeutic effects. Additionally, it has been hard to find cannabis products whose potency is uniform in order to trigger repeatable outcomes in patients. To compound matters even further, CBD normally brings therapeutic effects at a certain specific concentration. Anything greater or lower than that optimum level reduces its efficacy. The marijuana industry has responded to these challenges by getting more clinical and scientific.
Stratos, a cannabis company based in Colorado, is one of those entities which have stepped up to provide medical cannabis products that are consistent in terms of potency. Their products are so precise that splitting a tablet in half is a guaranteed way to take just half of the dose indicated on the product label.
Charlotte Payton, the VP of Development and Co-founder of Stratos, revealed that the company leveraged the roots of its founders in the medical arena to find ways to bring the consistency which is a given in other industries to the medical cannabis space. She wondered why people would easily get reliability and consistency in pharmaceuticals but not cannabis. Strato’s solution addressed that issue.
GoFire is another healthcare technology company which is also blazing a trail in finding solutions to deliver consistency in the medical cannabis industry. One of the products which they have brought to market is called the GoFire Inhaler. The inhaler’s unique convection heating system, precision dosing mechanism and medical-grade materials and design have just been patented.
The inhaler made by GoFire was designed for medicines extracted from plants, so patients can use this product to take cannabis flower and concentrates. Buyers of the inhaler also get an app which allows them to track and document their dosage preferences in addition to connecting with a community of other users of the GoFire Inhaler.
The work of these two companies has been welcomed by both medical professionals and patients. One such professional who was full of praises for the inhaler is Denver-based Dr. Michael Keller. He said such devices help to ease some of the concerns that members of the medical community have about prescribing medical marijuana products. The possibility of recommending exactly how much a patient should consume at a given frequency brings medical marijuana closer to what is expected of any therapeutic product.
VPR Brands LP (OTC: VPRB) and VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) applaud the innovations introduced by Stratos and GoFire since these technologies will bring medical cannabis closer to becoming a mainstream way to treat or manage different health conditions.
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have a questions or are you interested in working with CNW420? Ask our Editor